Constipation Clinical Trial
Official title:
A Pilot Participant-blind Study of the Effect of Bran, Psyllium and Nopal on Intestinal Water Content Using Magnetic Resonance Imaging
This study will compare 3 food products (bran, psyllium and nopal) on intestinal water content measured via MRI.
BACKGROUND AND RATIONALE
The role of dietary fibre in human health is a topic of both debate and research.
Interpreting evidence is complicated by changes in the definition of fibre. In the UK the
Scientific Advisory Committee for Nutrition has recently proposed a definition of "all
carbohydrates that are neither digested nor absorbed in the small intestine and have a degree
of polymerisation of three or more monomeric units, plus lignin". They have also called for
further research into the physiological effects of fibre of the gastrointestinal (GI) tract.
The Nottingham GI MRI group has been at the forefront of elucidating the effects of poorly
digested carbohydrates on gastrointestinal physiology. The investigators have published
techniques to measure free water in the small bowel and assessment of the physical form of
chyme in the colon using MR relaxometry. This includes the demonstration that fructose
ingestion on its own leads to increased free water in the small bowel compared to
co-ingestion with glucose.
Bran is often confused with dietary fibre. Although it contains fibre, the term actually
refers to the outer husk of seeds and grains. It has been shown to accelerate oro-caecal
transit (OCT) with scintigraphy. Bran can also be shown to increase small bowel water
content, possibly by mechanical stimulation, one of the most powerful stimuli for small
intestinal secretion, which may be a mechanism to prevent blockage. In the past bran's high
fibre content led to the hypothesis that its effect derived from holding water in the lumen
but a comparison study of 17 different fibres found an inverse relationship between their
water-holding properties and effect on faecal weight, with bran holding the least water but
inducing the largest weight changes. Rather, weight change appeared to relate to the amount
of undigested fibre present in the faeces and the associated changes in bacterial numbers,
which account for most of dry stool weight.
In contrast, psyllium husk contains a fibre that binds water effectively. On this basis it
has been used as a laxative for thousands of years. In fact, there is little evidence that
psyllium accelerates whole gut transit time as might be expected of a laxative. Work within
the investigating group has shown that psyllium increases water in both the small bowel and
the faeces, leading to softer, looser stool.
Nopal is a Mexican dietary product derived from cactus. It contains a different mix of fibre,
2/3rds of which is insoluble like bran fibre and 1/3rd soluble like psyllium. It is the
subject of several health claims. The investigating group has recently been awarded a grant
by the Newton Fund, through the Medical Research council, to study its effects on gut
function. The aim of the Newton Fund is to stimulate collaborative research with
middle-income countries such as Mexico. Part of the project plan is to invite a Mexican
radiologist, Dr Alfonso Gil-Valadez, to Nottingham to learn about the MRI techniques used by
our group.
TRIAL OBJECTIVES AND PURPOSE
Purpose
The purpose of the study is to gather pilot data on the effect of Nopal on intestinal water
content, in comparison to bran and psyllium.
Objective
The primary objective is to gather pilot data on the change from baseline in small bowel
water content in healthy volunteers after a meal containing nopal, in comparison to meals
containing psyllium or bran.
Secondary Objectives
Secondary objectives will be to gather pilot data on the effects of the fibre-containing
meals on the physical form of colonic chyme, colonic volume and breath markers of
fermentation.
Hypotheses
The test meals will lead to differences in post-prandial water in the small bowel.
The test meals will lead to differences in the post-prandial volume and physical composition
of chyme in the colon.
The test meals will not lead to change in breath markers of fermentation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Recruiting |
NCT06292949 -
Clinical Study of Resistant Starch in Improving Constipation
|
N/A | |
Recruiting |
NCT04132661 -
MRI Assessment of Mode of Action of Bisacodyl, Single Dose
|
Phase 4 | |
Completed |
NCT02726295 -
The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study
|
Phase 4 | |
Terminated |
NCT02839889 -
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
|
Phase 4 | |
Recruiting |
NCT02255747 -
Anal Dilatation for Infants and Children With Constipation
|
N/A | |
Completed |
NCT02246647 -
Biomarkers for Intestinal Permeability in Patients With Constipation
|
||
Completed |
NCT01566409 -
Maintenance Treatment for Children With Constipation
|
N/A | |
Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
Completed |
NCT01695915 -
Diurnal Variation in Rectal Diameter
|
N/A | |
Completed |
NCT02658201 -
Ultrafast MRI Imaging to Exclude Constipation
|
N/A | |
Completed |
NCT02863848 -
Effect of Inulin-type Fructans on Constipated Children.
|
N/A | |
Completed |
NCT01438567 -
A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy
|
Phase 3 | |
Completed |
NCT01474499 -
A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation
|
Phase 3 | |
Completed |
NCT01411501 -
Efficacy and Safety of Acupuncture for Functional Constipation
|
Phase 3 | |
Completed |
NCT01170039 -
The Effectiveness of Lubiprostone in Constipated Diabetics
|
Phase 4 | |
Completed |
NCT00931853 -
Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).
|
Phase 3 | |
Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
Completed |
NCT00994851 -
Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.
|
Phase 3 | |
Terminated |
NCT01003249 -
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
|
Phase 4 |